argenx sells $1bn of stock
![argenx_PA_575_375](https://assets.euromoneydigital.com/dims4/default/b1aee81/2147483647/strip/true/crop/575x375+0+0/resize/840x548!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F94%2Fb2%2F741293504b27a85a788014b30775%2Fargenx-pa-575-375.jpg)
Dutch biotech firm argenx has tapped equity investors for $1bn (€830.3m) to finance research and development.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: